Autophagy and Cardiometabolic Diseases

Autophagy and Cardiometabolic Diseases

From Molecular Mechanisms to Translational Medicine

1st Edition - April 12, 2018

Write a review

  • Authors: Jun Ren, James R. Sowers, Yingmei Zhang
  • Paperback ISBN: 9780128052532
  • eBook ISBN: 9780128054420

Purchase options

Purchase options
DRM-free (Mobi, EPub, PDF)
Sales tax will be calculated at check-out

Institutional Subscription

Free Global Shipping
No minimum order


Autophagy and Cardiometabolic Diseases: From Moleculer Mechanisms to Translational Medicine covers the science of autophagy in relation to cardiometabolic diseases and the future therapeutic potentials of autophagy regulation in these processes. Processes are not described in isolation, but in concert with other cellular and/or metabolic processes, such as lipogenesis, glucose, energy metabolism and apoptosis. This approach recognizes the multifactorial nature of cardiometabolic diseases, including obesity, diabetes, insulin resistance, hypertension and dyslipidemia. The book provides explanations, while also distinguishing the delicate role for autophagy in pathogenesis and exploring complications for cardiometabolic diseases. By targeting autophagy, it offers new avenues for drug discovery and treatment for cardiometabolic anomalies. It is a perfect resource for cardiology researchers, scientists and medical practitioners.

Key Features

  • Explains the processes inherent in the protein quality control for pathogenesis and complications of cardiometabolic diseases
  • Provides knowledge from internationally recognized contributors in the field
  • Incorporates a translational approach, covering the basic cellular biology of autophagy and presenting the role of autophagy regulation for both pathogenesis and complication in cardiometabolic diseases
  • Contains access to a companion website with additional illustrations


Researchers from both academia and industry working in the field of cardiovascular disease and biomedical sciences, medical practitioners, pharmaceutical industry workers, and health professional students

Table of Contents

  • Section I. Cell biology of cardiometabolic syndrome and autophagy
    1. Overview of autophagy and cardiometabolic syndrome
      Annayya R. Aroor, Guanghong Jia and James R. Sowers
    2. Overview of autophagy and its molecular regulation
      Xi Ma, Linsen Li, Ting He, Michael A. Brown and Qing Zhong
    3. Interplay among oxidative stress, redox signaling, ER stress, autophagy, and protein ubiquitylation in cardiometabolic disorders
      Taixing Cui and Xuejun Wang
    4. Mechanism and regulation of selective mitophagy in cardiometabolic disease
      Zhi Yang, Jianjun Lv, Jun Ren and Dongdong Sun
    5. Experimental models and measurement of autophagy
      Wei Zhu, Yong Sun, Yao-liang Tang, Chen Wang, Chang-Chen Xiao, Jing-Hai Chen, Hong Yu, Xin-Yang Hu and Jian’an Wang
    6. Role of autophagy in cardiac physiology and pathophysiology
      Valerie P. Tan and Shigeki Miyamoto

    Section II. Autophagy and pathogenesis of cardiometabolic disease
    7. Autophagy and diabetes mellitus
      Yingmei Zhang
    8. Autophagy and hypertension
      Feng Cao and Sai Ma
    9. Myocardial insulin signaling and autophagy
      Jordan Bartlett, Trivedi Purvi, Brian Rodrigues and Thomas Pulinilkunnil
    10. Autophagy as a therapeutic target for cardiovascular complications in obesity - concepts, controversies, and challenges
      Jun Ren and Yingmei Zhang
    11. Autophagy and lipid metabolism in cardiometabolic diseases
      Mingjie Yang, Yingmei Zhang and Jun Ren
    12. Autophagy and stroke
      Pei Wang and Chao-Yu Miao
    13. Polycystic ovary syndrome and cardiometabolic disease
      Shuyi Wang, Amy M. Navratil and Jun Ren
    14. The role of autophagy in vascular biology and atherosclerosis
      Ida Perrotta
    15. Autophagy and proteostasis in cardiac aging
      Dai Dao-Fu and Peter S. Rabinovitch
    16. Novel pathways of autophagy for the treatment of nervous system disorders
      Kenneth Maiese

    Section III. Autophagy and complications of cardiometabolic disease
    17. Autophagy and liver disease
      Sergi Guixé-Muntet and Jordi Gracia-Sancho
    18. Chaperone-mediated autophagy and kidney disease
      Lu Wang, Ying Han and Jun Ren
    19. Autophagy and fetal programming
      Alina Maloyan
    20. Autophagy, oxidative stress and redox regulation
      Jipeng Ma, Lifang Yang, Jun Ren and Jian Yang

    Section IV. Translational approach of autophagy
    21. Autophagy-driven cancer drug development
      Amine Belaid, Barnabé Roméo, Harilaos Filippakis, Mickael Meyer, Guillemette Crépeaux, Romain K Gherardi, Dominique Lagadic-Gossmann, Martin Von Bergen, Abderrahman Chargui, Eric Gilson, Delphine Benarroch-Popivker, Patrick Brest, Paul Hofman and Baharia Mograbi
    22. Autophagy: a new therapeutic target
      Asli F. Ceylan
    23. Autophagy regulates control of intracellular energy stores
      Michael N. Sack
    24. Autophagy and epigenetics
      Xu-Dong Wang, Thomas G. Gillette and Zhao V. Wang
    25. Autophagy, exercise and life style modification
      Donny Camera and William J. Smiles

Product details

  • No. of pages: 340
  • Language: English
  • Copyright: © Academic Press 2018
  • Published: April 12, 2018
  • Imprint: Academic Press
  • Paperback ISBN: 9780128052532
  • eBook ISBN: 9780128054420

About the Authors

Jun Ren

Dr. Jun Ren, MD, PhD, FAHA, is a Professor and Associate Director in University of Wyoming Biomedical PhD Graduate Program. He is also an Adjunct Professor of Cardiology in the Department of Cardiology, Zhongshan Hospital Fudan University. He is a member of American Heart Association and Diabetes Association National Center Study Sections. Dr. Ren specializes in the molecular cardiology with the goal that is to develop a strategy to prevent cardiovascular and a better regimen of treating these disorders. Serving as PI on several federal or national grants, he has completed enormous researches arming him with experience in cardiac function and structure assessment. In addition, he successfully administered the projects (e.g. staffing, research protections, budget), supervised students, and collaborated with other researchers. He has published over 500 articles with a main research interests in Cardiovascular and neurodegenerative diseases.

Affiliations and Expertise

Associate Dean of Research, Professor, College of Health Sciences, University of Wyoming, Wyoming, USA

James R. Sowers

James R. Sowers, MD, is Professor of Medicine, Physiology/Pharmacology and Director of the Endocrinology, Diabetes & Metabolism Division at the University Of Missouri, School Of Medicine. In addition, he is the Director of the Thomas and Joan Burns Cardiovascular and Diabetes Research Center and holds the Thomas W. and Joan F. Burns Missouri Chair in Diabetology. Dr. Sowers serves as a reviewer on several study sections for the National Institutes of Health and for the Department of Veterans Affairs. He is the editor of Cardiorenal Medicine, Associate Editor of Diabetes and on editorial boards of Hypertension, Endocrinology, and Metabolism. In the last year Dr. Sowers has published more than 25 peer-reviewed papers. Dr. Sowers achieved the Irvin Page Lifetime Achievement Award from the American Heart Association in 2012. He serves as a PI on one NIH funded grant and a VA Merit grant, and is a Co-Investigator on several NIH grants with colleagues at the University of Missouri, as well as other research colleagues at academic institutions around the country. Dr. Sowers has been examining the cellular mechanisms of insulin action in cardiovascular, renal and skeletal muscle tissue for three decades, focusing primarily on in vitro and in vivo/ex-vivo studies of animal models. Recently his research has been directed to the role of over-nutrition/angiotensin II, aldosterone, estrogen, and immune function on T regulatory cells and in site-specific serine phosphorylation of insulin sensitivity and associated cardiovascular functional abnormalities. As part this continuing cardiovascular renal diabetes research program, his program plans to pursue the role of angiotensin II, aldosterone and sex differences in metabolic cardiovascular insulin resistance in mice subjected to a “Westernized” diet.

Affiliations and Expertise

Professor of Medicine, Physiology/Pharmacology and Director of the Endocrinology, Diabetes and Metabolism Division, University of Missouri, School of Medicine

Yingmei Zhang

Yingmei Zhang, MD, PhD, FACC, is a Professor and Attending Cardiologist in the Department of Cardiology, Zhongshan Hospital Fudan University. She also serves as an adjunct Assistant Professor in the College of Health Science at the University of Wyoming. She is a Yangtze River scholar Professor (Youth Scholar Program) and a winner of National Science Fund for Excellent Young Scholars. Prof. Zhang is also a member of Basic Research Group in the Chinese medical association cardiovascular branch. She received her Master’s and doctoral degrees from the Fourth Military Medical University and completed post-doctoral training at the University of Wyoming. She has over 60 publications in the area of pathogenesis and therapeutics of myocardial dysfunction focusing on the regulation of mitochondrial function and autophagy. Her research has been supported by the Natural Science Foundation of China, National Institute of Health (NIH) and American Diabetes Association (ADA). She serves as an editor or on editorial board for several scientific journals. Her scientific contributions encompass (1) revealing mechanism(s) behind myocardial mitochondrial injury under ER stress; (2) depicting the beneficial role for endogenous myocardial proteins including mitochondrial aldehyde dehydrogenase (ALDH2) and insulin-like growth factor I (IGF-1) under metabolic syndrome.

Affiliations and Expertise

Professor and Attending Cardiologist, Department of Cardiology, Zhongshan Hospital Fudan University

Ratings and Reviews

Write a review

There are currently no reviews for "Autophagy and Cardiometabolic Diseases"